GT Apeiron Therapeutics Company
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology.
Founded Date:
2019-01-01
Technology:
Biotechnology, Health Care, Therapeutics
Total Funding:
27000000.0
Employee Number:
11-50
Headquarters:
Shanghai, Shanghai, China
Last Funding Date:
2019-06-11
Investors Number:
1.0
Last Funding Type:
Venture - Series Unknown
Estimated Revenue:
$1M to $10M
Industry:
Early Drug Development